Principal Investigator: Professor Roger Sturmey, University of Hull
561 results
With a decade of NC3Rs funding, scientists at the University of Birmingham have developed the first mature bone organotypic model, then systematically adapted and modified it to replace the use of rodents across a range of therapeutic areas involving the study of bone growth and regeneration.
Professor Anthony Chalmers and Co-Investigator Dr Natividad Gomez-Roman have further developed a 3D human cell culture model replacing the use of mice to evaluate and screen treatments for Glioblastoma (GBM).
Principal Investigator: Dr Carina Dunlop, University of Surrey
Principal Investigator: Dr Pierre-Alexis Mouthuy, University of Oxford
Dr Alan Harper and NC3Rs-BHF PhD student Jacob Ranjbar have developed an artificial human blood vessel to study blood clotting in vitro and replace the use of mice in thrombosis research. They have successfully disseminated the model to the thrombosis community, including for new applications within cardiovascular research.
Dr Frank McCaughan and student, Dr Phil Barry, miniaturised a human cell-based model of early-stage lung cancer enabling the assay to replace some drug screening experiments using mice.
Principal Investigator: Dr Richard van Arkel, Imperial College London
Principal Investigator: Dr Gowsihan Poologasundarampillai, University of Birmingham
Principal Investigator: Dr Peter Rugg-Gunn, Babraham Institute Cambridge
Principal Investigator: Dr Inés Cebola, Imperial College London
Principal Investigator: Dr Anna Krasnodembskaya, Queen's University Belfast
Principal Investigator: Dr Michael Colman, University of Leeds
Principal Investigator: Dr Gabriel Galea, University College London
Current contact: Dr Ellen Forty,
Current contact: Dr Elliot Lilley,
Professor Cathy Merry has developed synthetic hydrogels that support 3D culture for multiple cell types and used NC3Rs funding to support their application across multiple scientific disciplines.
Dr Karl Butterworth and PhD Student Dr Kathryn Brown have applied high precision cancer radiotherapy techniques used to treat human patients to improve the reproducibility and translatability of preclinical animal trials.
Dr Paola Campagnolo has used NC3Rs funding from a Project grant and a Skills and Knowledge Transfer award to develop an ex vivo model of the epicardium to replace the use of mice for high throughput screening of cardiac therapies in academia and industry.
Principal Investigator: Professor Robert Hindges, King's College London
